SITC Cutaneous Melanoma Immunotherapy Guideline

The Society for Immunotherapy of Cancer (SITC) published the first Clinical Practice Guideline (CPG) on immunotherapy for the treatment of Cutaneous Melanoma in Nature Reviews Clinical Oncology in 2013.

On May 30, 2018, SITC published an update in the Journal for ImmunoTherapy of Cancer (JITC), the society's open access, peer-reviewed online journal.

SITC's Cancer Immunotherapy Guidelines program is a collection of CPGs developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure the recommendations are unbiased, transparent and balanced will aid oncologists in effective clinical decision-making concerning patient selection, toxicity management, response evaluation, and the sequencing or combination of therapies, among other topics.

This update to the Cutaneous Melanoma CPG was developed collaboratively through the efforts of an expert panel that convened to discuss the current therapeutic landscape. This CPG provides recommendations for the use of immunotherapies including checkpoint inhibitor monotherapies and combinations, as well as oncolytic viruses, interferon-α2, and interleukin-2 in various disease stages and settings. Additionally, the CPG include discussion for patient selection, sequencing or combination of therapies, using and screening for predictive biomarkers, managing adverse events, selecting optimal clinical endpoints, and patient quality of life issues.

Published Guideline and Algorithms

Published May 30, 2018 in Journal for ImmunoTherapy of Cancer (JITC) as "An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0."

Updated July 27, 2018 Current treatment algorithms for the SITC Cancer Immunotherapy Guidelines - Cutaneous Melanoma.

view guideline

view algorithm

On-demand Webinar

SITC is pleased to offer free live and on-demand webinars featuring Expert Panel members from SITC's Cutaneous Melanoma Guideline. These educational offerings are designed for healthcare providers who treat cancer patients including oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants. The live webinars include a dedicated question-and-answer session providing the opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.

SITC Clinical Practice Guideline Webinar – Immunotherapy for the Treatment of Cutaneous Melanoma
SITC hosted this session on July 30, 2018 - VIEW ON-DEMAND

In this introductory webinar, Expert Panel members provide attendees with an overview of the published guideline and highlight selected recommendations that are applicable to some of the most common scenarios clinicians may encounter while treating their patients with immunotherapy. After attending this webinar, learners will be better able to implement immunotherapy treatments effectively and in accordance with the recommendations in the SITC CPG.

SITC Cutaneous Melanoma Immunotherapy Expert Panel

CHAIR Ryan J. Sullivan, MD Massachusetts General Hospital	CHAIR Anna C. Pavlick, DO, MBA New York University Cancer Institute

SITC Cutaneous Melanoma Immunotherapy Guideline

Published Guideline and Algorithms

On-demand Webinar

SITC Cutaneous Melanoma Immunotherapy Expert Panel

CHAIR

CHAIR

Membership Links

Get Involved